GleamWall
中文EN

FTRE Fortrea Holdings Inc.

Services-Medical Laboratories · Nasdaq · SEC CIK 1965040 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-3.4%
TTM net income YoY93.2%
TTM EPS YoY94.1%
Revenue 3-yr CAGR-2.7%
Net income 3-yr CAGR—

Margins

Gross margin20.0%
Operating margin0.5%
Net margin-2.6%
FCF margin6.3%
EBITDA margin3.4%

Returns

ROE-12.3%
ROA-2.5%
ROIC (approx.)0.7%
Asset turnover0.97x

Leverage & solvency

Liabilities / assets80.6%
Debt / equity1.98x
Current ratio0.97x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-2.94x
Accruals ratio-9.9%
Payout ratio—
Capex / revenue1.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$691.50M$678.20M$636.50M$660.50M$701.30M$710.30M$651.30M$697.00M
Cost of revenue$552.00M$539.00M$512.90M$529.40M$578.60M$576.80M$534.80M$556.10M
Gross profit$139.50M$139.20M$123.60M$131.10M$122.70M$133.50M$116.50M$140.90M
SG&A expense$103.80M$102.10M$100.50M$103.00M$106.80M$124.80M$121.80M$148.10M
Operating income$15.00M$14.80M-$3.40M-$13.60M-$8.60M-$330.30M-$520.10M-$55.60M
Pretax income-$3.60M-$1.20M-$12.30M-$35.60M-$28.70M-$370.70M-$548.00M-$74.90M
Income tax-$4.20M$12.00M$11.30M-$3.10M-$12.80M$4.20M$14.90M-$1.00M
Net income$600,000-$13.20M-$23.60M-$32.50M-$15.90M-$374.90M-$562.90M-$61.20M
EBITDA$35.00M$34.40M$16.40M$5.70M$11.00M-$310.70M-$500.60M-$34.80M
EPS (basic)0.01-0.14-0.25—-0.17-4.14-6.25—
EPS (diluted)0.01-0.14-0.25—-0.17-4.14-6.25—
Weighted avg. shares (diluted)101.20M94.80M93.60M—91.20M90.60M90.10M—
Balance sheet
Cash & equivalents$220.60M$168.60M$147.50M$174.60M$131.30M$81.20M$101.60M$118.50M
Current assets$952.70M$923.60M$881.50M$897.20M$918.50M$960.00M$970.30M$948.20M
Goodwill$949.90M$950.30M$950.80M$960.00M$958.10M$965.20M$1.24B$1.71B
Intangibles$572.00M$586.80M$601.70M$622.00M$635.40M$654.30M$651.30M$655.70M
Total assets$2.74B$2.71B$2.68B$2.72B$2.74B$2.84B$3.12B$3.58B
Current liabilities$983.30M$963.70M$929.10M$913.30M$914.40M$942.30M$999.10M$949.50M
Short-term debt$23.40M$17.10M$10.90M$4.80M$74.50M$74.80M$163.80M$74.80M
Long-term debt$1.03B$1.04B$1.04B$1.05B$1.05B$1.10B$1.05B$1.05B
Total debt$1.06B$1.05B$1.05B$1.05B$1.13B$1.18B$1.21B$1.12B
Total liabilities$2.21B$2.19B$2.16B$2.15B$2.16B$2.25B$2.26B$2.22B
Shareholders' equity$532.30M$524.20M$525.90M$563.50M$580.80M$589.20M$858.80M$1.36B
Net debt$834.70M$885.70M$906.00M$878.20M$995.30M$1.09B$1.11B$1.01B
Shares outstanding96.50M95.10M94.60M93.10M92.20M90.80M90.50M89.70M
Cash flow statement
Operating cash flow$60.80M$28.90M-$17.00M$129.10M$86.80M$21.80M-$124.20M$17.10M
Capital expenditure$8.30M$9.00M$8.00M$7.50M$7.30M$7.50M$2.90M-$3.20M
Free cash flow$52.50M$19.90M-$25.00M$121.60M$79.50M$14.30M-$127.10M$20.30M
Investing cash flow-$8.30M-$7.00M-$8.00M-$7.50M$13.30M-$7.50M$16.10M$3.50M
Financing cash flow$0$0$0-$75.70M-$50.00M-$39.00M$88.40M-$1.10M
Depreciation & amortization$20.00M$19.60M$19.80M$19.30M$19.60M$19.60M$19.50M$20.80M
Stock-based compensation$12.00M$12.60M$11.40M$14.80M$22.30M$22.70M$14.60M$15.30M

Free plan shows the latest 8 periods; Pro shows all 19 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.